Brussels partner Matthew Hall spoke on March 22 at the Medicines for Europe, 13th Legal Affairs Conference, in London. He covered EU and UK antitrust issues arising out of pharma patent settlements in the EU. Medicines for Europe was formerly called the European Generic and Biosimilar Medicines Association and before that the European Generic Medicines Association (EGA). It is a Brussels-based trade association for the European generic pharma and biosimilars industries.
For more information please click here. The panel’s presentation is available here.